GiusepApe C.
- Country
- Italy
- Department
- #3653 - Presidio Ospedaliero San Bortolo
Research Overview
Data & Insights
Has run more than one trial at 0 of 35 partner sites.
Specializations
Hematologic Oncology
Focuses on leukemia and lymphoma subtypes across adult and pediatric populations.
- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia (Philadelphia‑positive)
- Acute Lymphoblastic Leukemia (Philadelphia‑negative)
- Chronic Myeloid Leukemia
- Mantle Cell Lymphoma
- Diffuse Large B‑Cell Lymphoma
- Multiple Myeloma
- Myelofibrosis
- Chronic Immune Thrombocytopenia
Engages in studies targeting disease eradication, molecular remission, and novel targeted agents.
Solid Tumor Oncology
Addresses major solid cancers, with emphasis on gastrointestinal, breast, prostate, lung, and hepatobiliary malignancies.
- Gastric Cancer
- Gastroesophageal Adenocarcinoma
- Colorectal Cancer
- Estrogen Receptor‑Positive/HER2‑Negative Breast Cancer
- Ovarian Cancer
- Metastatic Castration‑Sensitive Prostate Cancer
- Non‑Small Cell Lung Cancer
- Hepatocellular Carcinoma
- Cholangiocarcinoma
- Pancreatic Ductal Adenocarcinoma
- Cervical Cancer
- Endometrial Cancer
Focuses on molecularly guided therapies, immuno‑oncology, and combination regimens.
Immunologic and Inflammatory Disorders
Investigates immune‑mediated skin, gut, and renal diseases, emphasizing biologic therapies and disease‑modifying strategies.
- Atopic Dermatitis
- Plaque Psoriasis
- Ulcerative Colitis
- IgA Nephropathy
- Autoimmune Hemolytic Anemia
- Chronic Immune Thrombocytopenia
- Prurigo Nodularis
- Nummular Dermatitis
Targets pathways of systemic inflammation and auto‑immunity.
Cardiovascular and Metabolic Diseases
Covers atherosclerotic cardiovascular disease, lipid abnormalities, and thrombotic conditions.
- Atherosclerotic Cardiovascular Disease
- Elevated Lipoprotein(a)
- Venous Thromboembolism
- Heart Failure with Reduced Ejection Fraction
- Chronic Kidney Disease with Systemic Inflammation
Focuses on risk reduction, novel lipid‑lowering agents, and anticoagulation strategies.
Rare Hematologic and Coagulation Disorders
Targets uncommon blood and bleeding disorders, exploring innovative replacement and gene‑based therapies.
- Paroxysmal Nocturnal Hemoglobinuria
- Hemophilia A
- Hemophilia B
- Thrombotic Thrombocytopenic Purpura
- Factor Xa Inhibitor‑related Urgent Intervention
Emphasizes hemostasis restoration and disease‑specific therapeutic advances.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.